Saranyah Kannuchamy, PhD

Saranyah Kannuchamy is a Contributing Xtalks Journalist. She has enjoyed writing since she was a college student. When she started her PhD, Saranyah realized she greatly enjoys writing in the sciences. Saranyah has a PhD in Biotechnology from SRM University in Chennai, India, and a MSc in Biotechnology from the Muthayammal College of Arts and Science in Namakkal, India.

FDA Encourages Tracheostomy Tube Reuse Due to Supply Shortages
tracheostomy tube shortage
News

HistoSonics’ Kidney Cancer Trial Using Non-Invasive Histotripsy Gets FDA Nod
HistoSonics histotripsy technology
News

LithoVue Elite Becomes First Ureteroscope System to Monitor Intrarenal Pressure in Real-Time
LithoVue Elite single-use ureteroscope system
News

Jesduvroq (daprodustat) is FDA Approved for Anemia due to Chronic Kidney Disease
Jesduvroq (daprodustat) is FDA Approved for Anemia due to Chronic Kidney Disease for Adults on Dialysis
News

Orthopedic Imaging System from Adaptix Gets FDA 510(k) Clearance
Adaptix's orthopedic imaging system
News

Tidepool Loop Is FDA Cleared as an Automated Insulin Dosing App for Type 1 Diabetes
Tidepool Loop
News

Nobelpharma America Launches Educational Website for TSC-Associated Facial Angiofibroma
Nobelpharma America Launches Educational Website for TSC-Associated Facial Angiofibroma
News

Eli Lilly Will Invest $450 Million to Increase Trulicity and Mounjaro Production
Eli Lilly to invest to increase Trulicity and Mounjaro production.
News

Lung Disease Diagnostic Xenoview Gets FDA Approval for Use with MRI
Xenoview
News

‘Never Miss’ Campaign for Prostate Cancer Awareness Launched by AstraZeneca and Merck
Prostate Cancer Awareness
News

Imaging Drug Cytalux (pafolacianine) Approved for Detection of Lung Cancer During Surgery
Imaging Drug Cytalux (pafolacianine)
News

Idacio Approved as Eighth Adalimumab Biosimilar in the US
Idacio (adalimumab-aacf)
News